Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer
Clinical trial NCT07162259 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07162259
- Sponsor
- Yan Xue
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.